Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Radka Bittenglová"'
Autor:
Monika Zurkova, Eva Kriegova, Vitezslav Kolek, Vladimira Lostakova, Martina Sterclova, Vladimir Bartos, Martina Doubkova, Ilona Binkova, Michal Svoboda, Jana Strenkova, Marketa Janotova, Martina Plackova, Ladislav Lacina, Vladimir Rihak, Frantisek Petrik, Pavlina Lisa, Radka Bittenglova, Richard Tyl, Gustav Ondrejka, Hana Suldova, Jaroslav Lnenicka, Jana Psikalova, Tomas Snizek, Jiri Homolka, Renata Kralova, Jan Kervitzer, Martina Vasakova, ILD section, IPF registry
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Introduction Pirfenidone, an antifibrotic drug, slows-down the disease progression in idiopathic pulmonary fibrosis (IPF) over 12 months, however limited data on the decline of lung function and overall survival (OS) in real-world cohorts on
Externí odkaz:
https://doaj.org/article/eb20517990ed4ee998a6eafe220aaf34
Autor:
Marianna Štefániková, Martina Doubková, Petra Ovesná, Martina Šterclová, Ladislav Lacina, Monika Žurková, Martina Plačková, Vladimír Bartoš, Ivana Janíčková, Radka Bittenglová, Jan Anton, Ľubica Sýkorová, Vladimíra Lošťáková, Pavlína Musilová, Hana Šuldová, Radka Mokošová, Jurij Didyk, Lenka Šišáková, Pavlína Lisá, Jaroslav Lněnička, Hana Dařičková, Daniel Doležel, Jana Pšikalová, Richard Tyl, Renata Králová, Martina Koziar Vašáková
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Introduction The antifibrotic drug nintedanib is used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the effect of nintedanib on antifibrotic treatment outcome in real-world cohorts of Czech EMPIRE registry. Patients/m
Externí odkaz:
https://doaj.org/article/354e93acae574d0789b4d40b679b4189
Autor:
Martina Sterclova, Martina Doubkova, Lubica Sykorova, Vladimir Bartos, Monika Zurkova, Vladimira Lostakova, Radka Mokosova, Martina Plackova, Ladislav Lacina, Michaela Cimrova, Radka Bittenglova, Pavlina Lisa, Pavla Musilova, Daniel Dolezal, Jana Psikalova, Petra Ovesna, Martina Koziar Vasakova
Publikováno v:
Pulmonary Medicine, Vol 2024 (2024)
There are limited data on referral rates and the number of patients with idiopathic pulmonary fibrosis (IPF) who are eligible for lung transplantation. The aim of the present study was to assess adherence to the consensus of the International Society
Externí odkaz:
https://doaj.org/article/94d509ca7d934c66ba732b7f4a1dc771
Autor:
Martina, Doubková, Michal, Uher, Vladimír, Bartoš, Martina, Šterclová, Ladislav, Lacina, Vladimíra, Lošťáková, Ilona, Binková, Martina, Plačková, Monika, Žurková, Radka, Bittenglová, Jana, Pšikalová, Lenka, Šišková, Pavlína, Lisá, František, Petřík, Jaroslav, Polák, Vladimír, Řihák, Jana, Skřičková, Martina, Vašáková
Publikováno v:
Casopis lekaru ceskych. 155(4)
Idiopathic pulmonary fibrosis (IPF) is a rare, progressive and usually fatal form of idiopathic interstitial pneumonia. IPF is characterized by failure of alveolar re-epithelization, persistence of fibroblasts, deposition of extracellular matrix, and
Autor:
Libor, Fila, Alžběta, Grandcourtová, Lucie Valentová, Bartáková, Zuzana, Antušová, Eva, Pokojová, Vladimír, Herout, Petr, Jakubec, Radka, Bittenglová, Miloslav, Marel
Publikováno v:
Vnitrni lekarstvi. 62(5)
There is an increasing number of cystic fibrosis (CF) patients with the diagnosis established in adulthood worldwide.To give an overview of our experience with the diagnostics of CF in adulthood in the Czech Republic.CF patients with the diagnosis de
Autor:
Martina Doubkova, Eva Kriegova, Simona Littnerova, Petra Schneiderova, Martina Sterclova, Vladimir Bartos, Martina Plackova, Monika Zurkova, Radka Bittenglova, Vladimira Lostaková, Lenka Siskova, Pavlina Lisa, Hana Suldova, Michael Doubek, Jana Psikalova, Tomas Snizek, Pavlina Musilova, Martina Vasakova
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 15 (2021)
Background: The antifibrotic drugs nintedanib and pirfenidone are used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the association of common profibrotic polymorphisms in MUC5B (mucin 5B, rs35705950) and DSP (desmoplakin, rs2
Externí odkaz:
https://doaj.org/article/f44baceebf1c45358ab4de31e662b434
Autor:
Radka Bittenglová, Marek Minarik, Josef Sampalík, Radka Slováèková, Franti∫ek Brùha, Miloš Pešek, Gabriela Krakorova, Lucie Bene∫ová
Publikováno v:
Journal of Thoracic Oncology. (8):S396-S397